Literature DB >> 19706717

Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice.

Young-Hee Jin1, Bongsu Kang, Byung S Kim.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV)-induced immune-mediated demyelinating disease in susceptible mouse strains has been extensively investigated as a relevant model for human multiple sclerosis. Previous investigations of antiviral T-cell responses focus on immune responses to viral capsid proteins, while virtually nothing is reported on immune responses to nonstructural proteins. In this study, we have identified noncapsid regions recognized by CD4(+) T cells from TMEV-infected mice using an overlapping peptide library. Interestingly, a greater number of CD4(+) T cells recognizing an epitope (3D(21-36)) of the 3D viral RNA polymerase, in contrast to capsid epitopes, were detected in the CNS of TMEV-infected SJL mice, whereas only a minor population of CD4(+) T cells from infected C57BL/6 mice recognized this region. The effects of preimmunization and tolerization with these epitopes on the development of demyelinating disease indicated that capsid-specific CD4(+) T cells are protective during the early stages of viral infection, whereas 3D(21-36)-specific CD4(+) T cells exacerbate disease development. Therefore, protective versus pathogenic CD4(+) T-cell responses directed to TMEV appear to be epitope dependent, and the differences in CD4(+) T-cell responses to these epitopes between susceptible and resistant mice may play an important role in the resistance or susceptibility to virally induced demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706717      PMCID: PMC2772789          DOI: 10.1128/JVI.01398-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice.

Authors:  J P Palma; H G Lee; M Mohindru; B S Kang; M Dal Canto; S D Miller; B S Kim
Journal:  J Neuroimmunol       Date:  2001-06-01       Impact factor: 3.478

2.  Induction of selected chemokines in glial cells infected with Theiler's virus.

Authors:  J P Palma; B S Kim
Journal:  J Neuroimmunol       Date:  2001-07-02       Impact factor: 3.478

3.  Coronavirus induced encephalomyelitis: an immunodominant CD4(+)-T cell site on the nucleocapsid protein contributes to protection.

Authors:  H Wege; A Schliephake; H Körner; E Flory; H Wege
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 4.  Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis.

Authors:  B S Kim; J P Palma; A Inoue; C S Koh
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2000       Impact factor: 4.291

5.  Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses.

Authors:  W J Karpus; J D Peterson; S D Miller
Journal:  Int Immunol       Date:  1994-05       Impact factor: 4.823

6.  Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system.

Authors:  J F Bureau; X Montagutelli; F Bihl; S Lefebvre; J L Guénet; M Brahic
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

7.  Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination.

Authors:  L C Pullen; S D Miller; M C Dal Canto; B S Kim
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

8.  Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.

Authors:  W J Karpus; J G Pope; J D Peterson; M C Dal Canto; S D Miller
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

9.  T cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46-61) in C57BL/6 mice.

Authors:  Y S Jang; J A Mikszta; B S Kim
Journal:  Mol Immunol       Date:  1994-08       Impact factor: 4.407

10.  A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).

Authors:  R L Yauch; B S Kim
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

View more
  10 in total

1.  Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

2.  Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Authors:  Derrick P McCarthy; Maureen H Richards; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2012

3.  Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.

Authors:  Jinjong Myoung; Hyun Seok Kang; Wanqiu Hou; Liping Meng; Mauro C Dal Canto; Byung S Kim
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

4.  Novel roles of the picornaviral 3D polymerase in viral pathogenesis.

Authors:  Jason Kerkvliet; Ramakrishna Edukulla; Moses Rodriguez
Journal:  Adv Virol       Date:  2010-01-01

5.  The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus.

Authors:  Young-Hee Jin; Wanqiu Hou; Hyun Seok Kang; Chang-Sung Koh; Byung S Kim
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

6.  Macrophage-mediated optic neuritis induced by retrograde axonal transport of spike gene recombinant mouse hepatitis virus.

Authors:  Kenneth S Shindler; Dhriti Chatterjee; Kaushiki Biswas; Ashish Goyal; Mahasweta Dutt; Mayssa Nassrallah; Reas S Khan; Jayasri Das Sarma
Journal:  J Neuropathol Exp Neurol       Date:  2011-06       Impact factor: 3.685

Review 7.  Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Byung S Kim
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

8.  IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.

Authors:  Byung S Kim; Young-Hee Jin; Liping Meng; Wanqiu Hou; Hyun Seok Kang; Hey Suk Park; Chang-Sung Koh
Journal:  J Neuroinflammation       Date:  2012-09-17       Impact factor: 8.322

9.  Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.

Authors:  Hyun Seok Kang; Jinjong Myoung; Eui Young So; Young Yil Bahk; Byung S Kim
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

10.  Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.

Authors:  Miriam Mecha; Francisco J Carrillo-Salinas; Leyre Mestre; Ana Feliú; Carmen Guaza
Journal:  Prog Neurobiol       Date:  2012-11-29       Impact factor: 11.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.